Split History
ETFs Holding EVOK »    EVOK Historical Stock Prices »



Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Evoke Pharma is a pharmaceutical company focused primarily on the development and commercialization of drugs to treat gastrointestinal disorders and diseases. Co. is focused on developing its primary product, Gimoti (metoclopramide) nasal spray. Gimoti is a dopamine antagonist / mixed 5-HT3 antagonist / 5-HT4 agonist for the relief of symptoms associated with acute and recurrent diabetic gastroparesis. Gimoti is a formulation of metoclopramide providing delivery by nasal spray administration. Co. is party to a commercial services agreement with Eversana Life Science Services, LLC, or Eversana, pursuant to which Eversana commercializes and distributes Gimoti in the U.S. According to our EVOK split history records, Evoke Pharma has had 1 split.
EVOK split history picture
Evoke Pharma (EVOK) has 1 split in our EVOK split history database. The split for EVOK took place on May 23, 2022. This was a 1 for 12 reverse split, meaning for each 12 shares of EVOK owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 83.3333333333333 share position following the split.

When a company such as Evoke Pharma conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the EVOK split history from start to finish, an original position size of 1000 shares would have turned into 83.3333333333333 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Evoke Pharma shares, starting with a $10,000 purchase of EVOK, presented on a split-history-adjusted basis factoring in the complete EVOK split history. EVOK split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 05/20/2014
End date: 05/17/2024
Start price/share: $86.40
End price/share: $0.47
Dividends collected/share: $0.00
Total return: -99.46%
Average Annual Total Return: -40.69%
Starting investment: $10,000.00
Ending investment: $53.86
Years: 10.00
Date Ratio
05/23/20221 for 12
EVOK is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

EW Split History
EXAC Split History
EYEG Split History
EYES Split History
FCSC Split History
FRX Split History
FVE Split History
GALE Split History
GALT Split History
GBSN Split History

Also explore: EVOK shares outstanding history

Email EnvelopeFree EVOK Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

OpGen, Inc. (OPGN)
Blue Star Foods Corp. (BSFC)
Charles & Colvard, Ltd. (CTHR)
Seelos Therapeutics, Inc. (SEEL)
Chimera Investment Corporation (CIM)
Advent Technologies Holdings, Inc. (ADN)
TIAN RUIXIANG Holdings Ltd (TIRX)
Telesis Bio Inc. (TBIO)
United States Lime & Minerals, Inc. (USLM)
Inspire Veterinary Partners, Inc. (IVP)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

EVOK Insider Buying

EVOK Split History | www.SplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.